Class I

Drug Recall: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

SoloVital · July 12, 2024

Reason for Recall

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

1,331 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0620-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

SoloVital Drug Recall: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles. | SafeCheck